ArticleEcancermedicalscience2026
Patterns of treatment failure and survival outcomes following definitive intensity-modulated radiotherapy in locally advanced head and neck squamous cell carcinoma: a single centre experience.
Article in Ecancermedicalscience, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
10 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: Locally advanced head and neck squamous cell carcinoma (LA-HNSCC) continues to have suboptimal outcomes, with locoregional and distant failures remaining a significant cause of morbidity and mortality despite advances in radiotherapy techniques. This study evaluated failure patterns and survival outcomes following definitive intensity-modulated radiotherapy (IMRT) in LA-HNSCC. Materials and methods: An ambispective analysis was conducted on LA-HNSCC patients who received definitive IMRT with weekly concurrent chemotherapy. Locoregional failures (both residual disease and new loco-regional recurrences) as well as distant metastases were identified. Patterns of failure were categorised as local, regional or distant. Kaplan-Meier method was used to assess survival outcomes and univariate and multivariate Cox regression models were utilised to identify factors associated with failures and survival. Results: A total of 332 patients were analysed, with a median age of 58 years; 94% had stage III-IVB disease and 83.1% received concurrent chemotherapy. At a median follow-up of 10 months, failure was observed in 44.9% of patients. Local control rates at 3, 6, 12 and 24 months were 97.9%, 81.6%, 69.9% and 52.5%, respectively. Local failure was the most common failure pattern (33.4%), followed by regional (15.6%) and distant failure (9.3%). Primary tumour volume greater than 30 cc and an oral cavity primary site were independent predictors of local failure. Median disease-free survival and overall survival were 8.3 and 13.8 months, respectively. Conclusion: Despite the use of modern IMRT techniques, locoregional failure - particularly local failure - remains the predominant pattern of treatment failure in LA-HNSCC. Primary tumour volume is a critical determinant of outcome, highlighting the need for volumetric risk stratification and individualised treatment strategies to improve disease control in high-risk patients. However, the interpretation of survival outcomes should be considered in light of the wide range of follow-up duration in this cohort, which represents a limitation of the present study.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.